Article
Glioblastomas: Hijacking Metabolism to Build a Flexible Shield for Therapy Resistance
22 Feb 2023
Abstract excerpt
Significance: Glioblastomas (GBMs) are among the most lethal tumors despite the almost exclusive localization to the brain. This is largely due to therapeutic resistance. Radiation and chemotherapy significantly increase the survival for GBM patients, however, GBMs always recur, and the median overall survival is just over a year. Proposed reasons for such intractable resistance to therapy are numerous and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
